Key facts
- This page summarizes Atlas Venture Fund VIII, L.P.'s Form 4 filing for INTEGRAL AD SCIENCE HOLDING CORP. (IAS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2025, 20:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Additional SEC filing notes
Section 16 status
Atlas Venture Fund VIII, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger, dated as of September 24, 2025 (the "Merger Agreement") by and among the Issuer, Igloo Group Parent, Inc., a Delaware corporation ("Parent"), and Igloo Group Acquisition Company, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, on December 23, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent. At the Effective Time, each share of common stock of the Issuer owned by the reporting persons immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $10.30 in cash, without interest thereon.
Footnote F2
Shares held directly by Atlas Venture Fund VIII, L.P. ("Atlas VIII"). Atlas Venture Associates VIII, L.P. ("AVA VIII LP") is the sole general partner of Atlas VIII. Atlas Venture Associates VIII, Inc. ("AVA VIII Inc.") is the sole general partner of AVA VIII LP. Each of Atlas VIII, AVA VIII LP and AVA VIII Inc. disclaim beneficial ownership of all shares except to the extent of its pecuniary interest, if any, therein. This report shall not be deemed to be an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.